New Vernon Capital Holdings II’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2,623
| Closed | -$261K | – | 89 |
|
2023
Q4 | $261K | Sell |
2,623
-237
| -8% | -$23.6K | 0.14% | 64 |
|
2023
Q3 | $295K | Buy |
2,860
+423
| +17% | +$43.7K | 0.26% | 44 |
|
2023
Q2 | $296K | Buy |
2,437
+820
| +51% | +$99.6K | 0.2% | 43 |
|
2023
Q1 | $248K | Buy |
1,617
+11
| +0.7% | +$1.69K | 0.18% | 39 |
|
2022
Q4 | $288K | Buy |
1,606
+226
| +16% | +$40.6K | 0.23% | 26 |
|
2022
Q3 | $163K | Sell |
1,380
-1,118
| -45% | -$132K | 0.17% | 39 |
|
2022
Q2 | $357K | Buy |
+2,498
| New | +$357K | 0.29% | 19 |
|